These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Blood types of current embryonic stem cell lines are not conducive to culturing "universal-donor" red blood cells. Bonig H; Chang KH; Geisen C; Seifried E; Ware C Transfusion; 2008 May; 48(5):1039-40. PubMed ID: 18454742 [No Abstract] [Full Text] [Related]
46. The preservation of blood for the purpose of transfusion. II. The effect of the rate of cooling on the preservation of erythrocytes. COLWELL LS; ELLENBERGER K; STRUMIA MM J Lab Clin Med; 1956 Nov; 48(5):769-74. PubMed ID: 13376978 [No Abstract] [Full Text] [Related]
47. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227 [TBL] [Abstract][Full Text] [Related]
48. [On results of statistical evaluation of complications in a central regional blood donor service (1958-1961)]. HAUSSMANN HG; LINDNER I; RICHTER M Bibl Haematol; 1963; 16():336-42. PubMed ID: 13961052 [No Abstract] [Full Text] [Related]
49. Occurrence of cold activation of transfusion plasma during storage at +4 degrees C. Suontaka AM; Silveira A; Söderström T; Blombäck M Vox Sang; 2005 Apr; 88(3):172-80. PubMed ID: 15787727 [TBL] [Abstract][Full Text] [Related]
50. Detection of hepatitis B virus deoxyribonucleic acid using real-time polymerase chain reaction method in pooled-plasma samples of Turkish blood donors. Karakoc AE; Berkem R; Beyaz E Clin Lab; 2009; 55(5-6):229-34. PubMed ID: 19728557 [TBL] [Abstract][Full Text] [Related]
51. Salvaging of liquid-preserved O-positive and O-negative red blood cells by rejuvenation and freezing. Ragno G; Robert Valeri C Transfus Apher Sci; 2006 Oct; 35(2):137-43. PubMed ID: 17035090 [TBL] [Abstract][Full Text] [Related]
52. Pathogen reduction technology: methods, status of clinical trials, and future prospects. Corash L Curr Hematol Rep; 2003 Nov; 2(6):495-502. PubMed ID: 14561394 [TBL] [Abstract][Full Text] [Related]
53. Studies on the preservation of human blood. I. Variability in erythrocyte storage characteristics among healthy donors. Dern RJ; Gwinn RP; Wiorkowski JJ J Lab Clin Med; 1966 Jun; 67(6):955-65. PubMed ID: 5916144 [No Abstract] [Full Text] [Related]
54. TRALI risk reduction: donor and component management strategies. Eder AF; Benjamin RJ J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816 [TBL] [Abstract][Full Text] [Related]
55. [Bacteriological problems of the contamination of preserved blood]. Gandrille MC; Thuillier M Rev Fr Transfus; 1973 Mar; 16(1):59-69. PubMed ID: 4794236 [No Abstract] [Full Text] [Related]
56. Perspectives of paid whole and plasma donation. Kretschmer V; Weippert-Kretschmer M; Slonka J; Karger R; Zeiler T Dev Biol (Basel); 2005; 120():101-11. PubMed ID: 16050162 [TBL] [Abstract][Full Text] [Related]
57. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617 [TBL] [Abstract][Full Text] [Related]
58. [EFFECT OF THE VITAMIN C SUPPLY TO THE BODY ON THE PHYSIOLOGICAL VALUE OF ERYTHROCYTES IN PRESERVED BLOOD]. BARKAGAN Ts; ROMENDIK LM Vopr Pitan; 1964; 23():28-33. PubMed ID: 14257988 [No Abstract] [Full Text] [Related]
59. [On the problem of studying plasmaphoresis in donors]. Gutnik RB Vrach Delo; 1966 Mar; 3():72-5. PubMed ID: 5990037 [No Abstract] [Full Text] [Related]
60. [Rheological efficacy of preserved blood in an in vitro transfusion model]. Buglov ED; Kostin GM Probl Gematol Pereliv Krovi; 1981 May; 26(5):20-4. PubMed ID: 7255360 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]